Free Trial
ASX:M7T

Mach7 Technologies (M7T) Stock Price, News & Analysis

About Mach7 Technologies Stock (ASX:M7T)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
272,627 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
3.37%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing, which includes eUnity zero-footprint viewer that connects departmental imaging from across the enterprise to deliver studies to care providers via the EMR. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content. In addition, the company provides Enterprise PACS, an enterprise-ready imaging platform; and professional services, such as implementation, training, support, and maintenance services, as well as project management. Mach7 Technologies Limited was incorporated in 1977 and is headquartered in South Burlington, Vermont.

Receive M7T Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mach7 Technologies and its competitors with MarketBeat's FREE daily newsletter.

M7T Stock News Headlines

Last time you’ll see this priced at $1.00
When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!
Mach7 Director Increases Investment in Company
Semler Scientific (NASDAQ: SMLR)
Bioventus (NASDAQ: BVS)
See More Headlines

M7T Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Mach7 Technologies investors own include Farfetch (FTCH), Eton Pharmaceuticals (ETON), Eqonex (EQOS), Denison Mines (DNN), Denali Therapeutics (DNLI), Carbios SAS (COOSF) and CleanSpark (CLSK).

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-7,970,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$29.13 million
Book Value
A$0.22 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.69
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:M7T) was last updated on 12/26/2024 by MarketBeat.com Staff
From Our Partners